Cargando…

Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment

Gastric cancer (GC) pathogenesis involves genetic, epigenetic and environmental factors. Epigenetic alterations, such as DNA methylation are considered pivotal in the inactivation of tumor-related genes. We assessed a methylation panel of 5 genes to study their association to GC progression and micr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Llorca-Cardeñosa, Marta Jessica, Fleitas, Tania, Ibarrola-Villava, Maider, Peña-Chilet, María, Mongort, Cristina, Martinez-Ciarpaglini, Carolina, Navarro, Lara, Gambardella, Valentina, Castillo, Josefa, Roselló, Susana, Navarro, Samuel, Ribas, Gloria, Cervantes, Andrés
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325374/ https://www.ncbi.nlm.nih.gov/pubmed/27566570 http://dx.doi.org/10.18632/oncotarget.11520

Ejemplares similares

Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer
por: Ibarrola-Villava, Maider, et al.
Publicado: (2015)

Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology
por: Ibarrola-Villava, Maider, et al.
Publicado: (2016)

Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications
por: Martinez-Ciarpaglini, Carolina, et al.
Publicado: (2019)

Sex-specific genetic effects associated with pigmentation, sensitivity to sunlight, and melanoma in a population of Spanish origin
por: Hernando, Barbara, et al.
Publicado: (2016)

Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy
por: Fleitas-Kanonnikoff, Tania, et al.
Publicado: (2019)

rs12512631 on the Group Specific Complement (Vitamin D-Binding Protein GC) Implicated in Melanoma Susceptibility
por: Peña-Chilet, Maria, et al.
Publicado: (2013)

Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Huerta, Marisol, et al.
Publicado: (2021)

In the literature: October 2021
por: Gambardella, V., et al.
Publicado: (2021)

Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish population
por: Peña-Chilet, Maria, et al.
Publicado: (2013)

RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines
por: Albanell-Fernández, Marta, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
por: Papaccio, Federica, et al.
Publicado: (2020)

Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress
por: Gambardella, Valentina, et al.
Publicado: (2020)

Personalized Medicine: Recent Progress in Cancer Therapy
por: Gambardella, Valentina, et al.
Publicado: (2020)

In the literature: December 2018
por: Gambardella, Valentina, et al.
Publicado: (2018)

Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer
por: Tarazona, Noelia, et al.
Publicado: (2020)

Involvement of ANXA5 and ILKAP in Susceptibility to Malignant Melanoma
por: Arroyo-Berdugo, Yoana, et al.
Publicado: (2014)

Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
por: Cabeza-Segura, Manuel, et al.
Publicado: (2022)

“Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”
por: Papaccio, Federica, et al.
Publicado: (2023)

In the literature: June 2019
por: Lamarca, Angela, et al.
Publicado: (2019)

RUNX Proteins as Epigenetic Modulators in Cancer
por: Yi, Hongyang, et al.
Publicado: (2022)

In the literature: February 2021
por: Cejalvo, J.M., et al.
Publicado: (2021)

RUNX Family in Hypoxic Microenvironment and Angiogenesis in Cancers
por: Lee, You Mie
Publicado: (2022)

Epigenetic Regulation of RUNX3 in Thyroid Carcinoma
por: Joung, Kyong Hye, et al.
Publicado: (2012)

Epigenetic inactivation of RUNX3 in colorectal cancer
por: Shin, Eung Jin, et al.
Publicado: (2018)

In the literature: December 2020
por: Gambardella, V., et al.
Publicado: (2021)

In the literature: December 2021
por: Montagut, C., et al.
Publicado: (2021)

Emerging role of RUNX3 in the regulation of tumor microenvironment
por: Manandhar, Sarala, et al.
Publicado: (2018)

RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis
por: Lichtinger, Monika, et al.
Publicado: (2012)

In the literature: July 2023
por: Gambardella, V., et al.
Publicado: (2023)

Vesicle-Mediated Control of Cell Function: The Role of Extracellular Matrix and Microenvironment
por: Rackov, Gorjana, et al.
Publicado: (2018)

Epigenetic Mechanisms Are Involved in the Oncogenic Properties of ZNF518B in Colorectal Cancer
por: Gimeno-Valiente, Francisco, et al.
Publicado: (2021)

Epigenetic regulation of Runx2 transcription and osteoblast differentiation by nicotinamide phosphoribosyltransferase
por: Ling, Min, et al.
Publicado: (2017)

Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study
por: Gambardella, Valentina, et al.
Publicado: (2021)

EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness
por: Gimeno-Valiente, F., et al.
Publicado: (2020)

The hematopoietic master regulator RUNX1 reshapes the epigenetic landscape at the onset of hematopoiesis
por: Lichtinger, Monika, et al.
Publicado: (2013)

ZNF518B gene up-regulation promotes dissemination of tumour cells and is governed by epigenetic mechanisms in colorectal cancer
por: Gimeno-Valiente, Francisco, et al.
Publicado: (2019)

miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic Biomarker
por: Oltra, Sara S, et al.
Publicado: (2020)

Epigenetic Repression of RUNX2 and OSX Promoters Controls the Nonmineralized State of the Periodontal Ligament
por: Gopinathan, Gokul, et al.
Publicado: (2023)

RUNX1 Ameliorates Rheumatoid Arthritis Progression through Epigenetic Inhibition of LRRC15
por: Ding, Hao, et al.
Publicado: (2023)

Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcomes at a single academic centre
por: Roselló, Susana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5hd1ujvl2gna2sfechjubance8